X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
35
PharmaCompass offers a list of Minoxidil API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Minoxidil manufacturer or Minoxidil supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Minoxidil manufacturer or Minoxidil supplier.
PharmaCompass also assists you with knowing the Minoxidil API Price utilized in the formulation of products. Minoxidil API Price is not always fixed or binding as the Minoxidil Price is obtained through a variety of data sources. The Minoxidil Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide, including repackagers and relabelers. The FDA regulates 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide supplier is an individual or a company that provides 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide active pharmaceutical ingredient (API) or 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide finished formulations upon request. The 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide suppliers may include 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide API manufacturers, exporters, distributors and traders.
click here to find a list of 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide DMF (Drug Master File) is a document detailing the whole manufacturing process of 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide active pharmaceutical ingredient (API) in detail. Different forms of 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide DMFs exist exist since differing nations have different regulations, such as 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide DMF submitted to regulatory agencies in the US is known as a USDMF. 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide USDMF includes data on 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide Drug Master File in Korea (2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide. The MFDS reviews the 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide KDMF as part of the drug registration process and uses the information provided in the 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide KDMF to evaluate the safety and efficacy of the drug.
After submitting a 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide API can apply through the Korea Drug Master File (KDMF).
click here to find a list of 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide suppliers with KDMF on PharmaCompass.
A 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide CEP of the European Pharmacopoeia monograph is often referred to as a 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide Certificate of Suitability (COS). The purpose of a 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide to their clients by showing that a 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide CEP has been issued for it. The manufacturer submits a 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide CEP (COS) as part of the market authorization procedure, and it takes on the role of a 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide CEP holder for the record. Additionally, the data presented in the 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide DMF.
A 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide suppliers with CEP (COS) on PharmaCompass.
A 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide written confirmation (2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide WC) is an official document issued by a regulatory agency to a 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide manufacturer, verifying that the manufacturing facility of a 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide APIs or 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide finished pharmaceutical products to another nation, regulatory agencies frequently require a 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide WC (written confirmation) as part of the regulatory process.
click here to find a list of 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide suppliers with NDC on PharmaCompass.
2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide GMP manufacturer or 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide GMP API supplier for your needs.
A 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide CoA (Certificate of Analysis) is a formal document that attests to 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide's compliance with 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide specifications and serves as a tool for batch-level quality control.
2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide CoA mostly includes findings from lab analyses of a specific batch. For each 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide may be tested according to a variety of international standards, such as European Pharmacopoeia (2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide EP), 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide USP).
Market Place
